Production problems

jar with capsules
Approval of an alternative angina treatment will not resolve potential shortages resulting from issues with an existing drug   The TGA advised recently that it had approved an alternative product to glyceryl trinitrate  (GTN) tablets, which are sold in Australia under the brand names Anginine and Lycinate, for treating acute angina pectoris (chest or heart

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Herbal medicines: what risks do they pose?
Next Most plan to keep MedsASSIST